Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings per share (EPS) is N/A as of the fiscal period ended Tuesday, September 30, 2025.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-03-31): -197.76.
EARNINGS PER SHARE (EPS)
N/A
EARNINGS PER SHARE (EPS) AVG TTM
N/A
EARNINGS PER SHARE (EPS) AVG 3Y
-21.04
EARNINGS PER SHARE (EPS) AVG 5Y
-1.64
EARNINGS PER SHARE (EPS) AVG 10Y
N/A
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
WORK Medical Technology Group Ltd. Class A
Market Cap
$3.63M
Earnings Per Share (EPS)
N/A
TTM Avg
N/A
3Y Avg
-21.04
5Y Avg
-1.64
Market Cap
$3.65M
Earnings Per Share (EPS)
-18.85
TTM Avg
-47.63
3Y Avg
-99.69
5Y Avg
-316.96
Market Cap
$3.65M
Earnings Per Share (EPS)
-0.91
TTM Avg
-1.99
3Y Avg
-3.92
5Y Avg
-2.83
Market Cap
$3.53M
Earnings Per Share (EPS)
-4.90
TTM Avg
-7.69
3Y Avg
-8.41
5Y Avg
-8.41
Market Cap
$3.50M
Earnings Per Share (EPS)
N/A
TTM Avg
-130.80
3Y Avg
-71.47
5Y Avg
-57.18
Market Cap
$3.49M
Earnings Per Share (EPS)
-0.45
TTM Avg
-1.48
3Y Avg
-5.05
5Y Avg
-8.12
Market Cap
$3.90M
Earnings Per Share (EPS)
-6.05
TTM Avg
-42.97
3Y Avg
-23.50
5Y Avg
-16.51
Market Cap
$3.93M
Earnings Per Share (EPS)
-211.18
TTM Avg
-432751.00
3Y Avg
-875189.50
5Y Avg
-22462429.83
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| WORK Medical Technology Group Ltd. Class A (WOK) | $3.63M | N/A | N/A | -21.04 | -1.64 |
| Ernexa Therapeutics Inc. (ERNA)vs › | $3.65M | -18.85 | -47.63 | -99.69 | -316.96 |
| Evogene Ltd. (EVGN)vs › | $3.65M | -0.91 | -1.99 | -3.92 | -2.83 |
| Cadrenal Therapeutics, Inc. Common Stock (CVKD)vs › | $3.53M | -4.90 | -7.69 | -8.41 | -8.41 |
| Moolec Science S.A. (MLEC)vs › | $3.50M | N/A | -130.80 | -71.47 | -57.18 |
| Eocene Ltd. (EOCN)vs › | $3.50M | N/A | N/A | N/A | N/A |
| Mustang Bio, Inc. (MBIO)vs › | $3.49M | -0.45 | -1.48 | -5.05 | -8.12 |
| 60 Degrees Pharmaceuticals, Inc. (SXTP)vs › | $3.90M | -6.05 | -42.97 | -23.50 | -16.51 |
| Aptevo Therapeutics Inc. (APVO)vs › | $3.93M | -211.18 | -432751.00 | -875189.50 | -22462429.83 |
| Nexalin Technology, Inc. (NXL)vs › | $3.30M | -14.40 | -19.95 | -16.43 | -17.45 |
Trailing EPS (TTM)
N/A
Forward EPS (Est.)
N/A
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-09-30 | -37.01 |
| 2024-09-29 | -27.00 |
| 2023-09-29 | 0.90 |
| 2022-09-29 | 6.92 |
| 2021-09-29 | 48.00 |
| 2020-09-29 | 1.16 |
